Argentina vs Hong Kong: The number of people with susceptibility test result for rifampicin
Argentina
2,309
in 2021
Hong Kong
2,181
in 2021
Argentina rank
44th
Hong Kong rank
45th
The number of people with susceptibility test result for rifampicin over time
- Argentina
- Hong Kong
How they compare
Argentina currently reports 2,309 against 2,181 in Hong Kong, a difference of 128.
That makes Argentina's figure about 1.1 times Hong Kong's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Hong Kong ahead.
Argentina ranks 44th and Hong Kong ranks 45th of 155 countries.
Hong Kong has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Hong Kong | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,204 | 2,387 | 1,183 | Hong Kong |
| 2020s | 1,732 | 2,143 | 411 | Hong Kong |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Argentina or Hong Kong?
- Argentina, at 2,309 against 2,181 in Hong Kong as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Argentina and Hong Kong?
- 128, with Argentina ahead.
- How many years of comparable data are there for Argentina and Hong Kong?
- 5 years are reported by both, from 2017 to 2021.
- How do Argentina and Hong Kong rank globally for the number of people with susceptibility test result for rifampicin?
- Argentina ranks 44th and Hong Kong ranks 45th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.